|Videos|September 4, 2019

ASRS 2019 Street Team: Chuck Hess

ICYMI: Chuck Hess, vice president and general manager of the U.S. Surgical Divison at Bausch + Lomb, shares what's in the company's surgical pipeline at the 2019 annual American Society of Retina Specialists meeting in Chicago.

Newsletter

Don’t miss out—get Modern Retina updates delivered straight to your inbox.

Subscribe

Related Content

Suprachoroidal space injection for the treatment of noninfectious uveitis

BySteven Yeh, MD, FASRS

July 22nd 2026

AMD lookback: Highlights from June 2026

ByKassi Filkins

July 10th 2026

Cynthia Toth, MD, of the Duke Department of Ophthalmology

Using OCT to predict neurodevelopmental risk in preterm infants: Cynthia Toth, MD

ByCytnthia Toth, MD,Lucia Gambuzza,Abigail Lewis, Content Intern

July 8th 2026

Redefining the possible: MCO-010’s 3-year retinal data

ByVinit Mahajan, MD, PhD,Sai Chavala, MD,Matt Hoffman

July 6th 2026

Could FLIO predict how fast geographic atrophy will grow?

ByModern Retina Staff

July 4th 2026

Latest CME

Video

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Neel Pasricha, MD; Asim V. Farooq, MD; Susana Campos, MD, MPH

Video

Treatment Optimization in the Evolving Anti-VEGF Era

Carl Danzig, MD, FASRS; Sruthi Arepalli, MD; Priya Vakharia, MD, FASRS

Video

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

ASRS 2019 Street Team: Chuck Hess

Related Content

Suprachoroidal space injection for the treatment of noninfectious uveitis

AMD lookback: Highlights from June 2026

Using OCT to predict neurodevelopmental risk in preterm infants: Cynthia Toth, MD

Redefining the possible: MCO-010’s 3-year retinal data

Could FLIO predict how fast geographic atrophy will grow?

Latest CME

Precision Vision: Integrating Mechanistic Insight and Clinical Strategy in ADC-Associated Ocular Toxicity

Treatment Optimization in the Evolving Anti-VEGF Era

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Trending on Eye Care Network - Ophthalmology Times

Retinal imaging as a window into atrial fibrillation

OCT-980 receives FDA orphan drug designation for retinitis pigmentosa

First patient dosed in phase 3 NPI-001 trial for Usher syndrome RP

Johnson & Johnson spotlights contrast data, 1 million TECNIS implants, and SmartLOAD delivery

The Wills Retina Report: Mapping gene therapy for wet AMD with Carl D. Regillo, MD, and Allen C. Ho, MD